Last updated: 28 May 2024 at 9:12am EST

Brian M. Culley M.A., M.B.A. Net Worth




The estimated Net Worth of Brian M Culley is at least $2.25 Million dollars as of 24 May 2024. Mr Culley owns over 10,000 units of Lineage Cell Therapeutics Inc stock worth over $133,969 and over the last 6 years he sold LCTX stock worth over $1,291,500. In addition, he makes $828,350 as CEO and Pres & Director at Lineage Cell Therapeutics Inc.

Mr A LCTX stock SEC Form 4 insiders trading

Mr has made over 19 trades of the Lineage Cell Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of LCTX stock worth $10,500 on 24 May 2024.

The largest trade he's ever made was selling 450,000 units of Lineage Cell Therapeutics Inc stock on 28 June 2021 worth over $1,291,500. On average, Mr trades about 33,442 units every 76 days since 2018. As of 24 May 2024 he still owns at least 154,842 units of Lineage Cell Therapeutics Inc stock.

You can see the complete history of Mr Culley stock trades at the bottom of the page.





Mr. Brian M. Culley M.A., M.B.A. biography

Brian M. Culley M.A., M.B.A. is the CEO, Pres & Director at Lineage Cell Therapeutics Inc.

What is the salary of Mr A?

As the CEO and Pres & Director of Lineage Cell Therapeutics Inc, the total compensation of Mr A at Lineage Cell Therapeutics Inc is $828,350. There are 1 executives at Lineage Cell Therapeutics Inc getting paid more, with Brandi Roberts having the highest compensation of $947,963.



How old is Mr A?

Mr A is 50, he's been the CEO and Pres & Director of Lineage Cell Therapeutics Inc since . There are 11 older and 4 younger executives at Lineage Cell Therapeutics Inc. The oldest executive at Lineage Cell Therapeutics Inc is Alfred Kingsley, 77, who is the Chairman of the Board.

What's Mr A's mailing address?

Brian's mailing address filed with the SEC is 2173 SALK AVENUE,, SUITE 200, CARLSBAD, CA, 92008.

Insiders trading at Lineage Cell Therapeutics Inc

Over the last 5 years, insiders at Lineage Cell Therapeutics Inc have traded over $2,612,743 worth of Lineage Cell Therapeutics Inc stock and bought 7,879,334 units worth $8,569,904 . The most active insiders traders include Partners, L.P.Broadwood Cap..., Alfred D Kingsley, and Brian M Culley. On average, Lineage Cell Therapeutics Inc executives and independent directors trade stock every 49 days with the average trade being worth of $212,992. The most recent stock trade was executed by Jill Ann Howe on 16 August 2024, trading 10,500 units of LCTX stock currently worth $9,345.



What does Lineage Cell Therapeutics Inc do?

biotime, inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies developed from what we believe to be the world's premier collection of pluripotent cell assets. the foundation of our core therapeutic technology platform is pluripotent cells that are capable of becoming any of the cell types in the human body. pluripotent cells have potential application in many areas of medicine with large unmet patient needs, including various age-related degenerative diseases and degenerative conditions for which there presently are no cures. unlike pharmaceuticals that require a molecular target, therapeutic strategies based on the use of pluripotent cells are generally aimed at regenerating or replacing affected cells and tissues, and therefore may have broader applicability than pharmaceutical products.



What does Lineage Cell Therapeutics Inc's logo look like?

Lineage Cell Therapeutics Inc logo

Complete history of Mr Culley stock trades at Lineage Cell Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
24 May 2024 Brian M Culley
President and CEO
Buy 10,000 $1.05 $10,500
24 May 2024
154,842
11 Feb 2024 Brian M Culley
President and CEO
Option 31,249 $1.08 $33,749
11 Feb 2024
157,648
11 Feb 2023 Brian M Culley
President and CEO
Option 31,249 $1.35 $42,186
11 Feb 2023
139,143
30 Jun 2022 Brian M Culley
President and CEO
Option 15,450 $1.58 $24,411
30 Jun 2022
113,237
31 Mar 2022 Brian M Culley
President and CEO
Option 15,450 $1.54 $23,793
31 Mar 2022
96,730
25 Mar 2022 Brian M Culley
President and CEO
Buy 5,250 $1.38 $7,245
25 Mar 2022
81,280
31 Dec 2021 Brian M Culley
President and CEO
Option 15,450 $2.45 $37,853
31 Dec 2021
81,373
30 Sep 2021 Brian M Culley
President and CEO
Option 15,450 $2.52 $38,934
30 Sep 2021
71,266
28 Jun 2021 Brian M Culley
President and CEO
Sale 450,000 $2.87 $1,291,500
28 Jun 2021
45,709
31 Mar 2021 Brian M Culley
President and CEO
Option 15,450 $2.35 $36,308
31 Mar 2021
201,052
31 Dec 2020 Brian M Culley
President and CEO
Option 15,450 $1.76 $27,192
31 Dec 2020
190,945
30 Sep 2020 Brian M Culley
President and CEO
Option 15,450 $0.94 $14,523
30 Sep 2020
180,838
30 Jun 2020 Brian M Culley
President and CEO
Option 15,450 $0.87 $13,442
30 Jun 2020
170,731
31 Mar 2020 Brian M Culley
President and CEO
Option 15,450 $0.83 $12,824
31 Mar 2020
160,624
31 Dec 2019 Brian M Culley
President and CEO
Option 15,450 $0.89 $13,751
31 Dec 2019
150,517
30 Sep 2019 Brian M Culley
President and CEO
Option 15,450 $0.98 $15,141
30 Sep 2019
140,410
17 Sep 2019 Brian M Culley
President and CEO
Option 61,800 $1.00 $61,800
17 Sep 2019
146,331
13 Aug 2019 Brian M Culley
President and CEO
Buy 10,000 $1.01 $10,100
13 Aug 2019
84,531


Lineage Cell Therapeutics Inc executives and stock owners

Lineage Cell Therapeutics Inc executives and other stock owners filed with the SEC include: